# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Jim Cramer discusses Torm, Trane, Sap and Axsome Therapeutics on CNBC's "Mad Money Lightning Round."
Evercore ISI Group analyst Jonathan Chappell maintains TORM (NASDAQ:TRMD) with a Outperform and raises the price target from...
U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday.
Evercore ISI Group analyst Jonathan Chappell maintains TORM (NASDAQ:TRMD) with a Outperform and raises the price target from...
By the end of today, February 14, 2024, Hess Midstream (NYSE:HESM) is set to deliver a dividend payout of $0.63 per share, equa...